M. Karcz-Kubicha

发表

Glutamate mGlu5-adenosine A2A-dopamine D2 receptor interactions in the striatum. Implications for drug therapy in neuro-psychiatric disorders and drug abuse

K. Fuxe, D. Marcellino, L. Agnati, 2003 .

Lack of adenosine A1 and dopamine D2 receptor-mediated modulation of the cardiovascular effects of the adenosine A2A receptor agonist CGS 21680.

C. Müller, E. Thorndike, S. Goldberg, 2004, European journal of pharmacology.

Developmental lead exposure impairs extinction of conditioned fear in young adult rats.

T. Guilarte, J. McGlothan, M. Karcz-Kubicha, 2008, Neurotoxicology.

Involvement of Adenosine A1 and A2A Receptors in the Motor Effects of Caffeine after its Acute and Chronic Administration

Katerina Antoniou, Sergi Ferré, K. Fuxe, 2003, Neuropsychopharmacology.

Synergistic interaction between adenosine A2A and glutamate mGlu5 receptors: Implications for striatal neuronal function

K. Fuxe, F. Ciruela, B. Hope, 2002, Proceedings of the National Academy of Sciences of the United States of America.

Stimulation of Adenosine Receptors Selectively Activates Gene Expression in Striatal Enkephalinergic Neurons

M. Morales, B. Hope, S. Goldberg, 2006, Neuropsychopharmacology.

Effects of post-ethanol administration of NMDA and non-NMDA receptor antagonists on the development of ethanol tolerance in C57BI mice

S. Liljequist, M. Karcz-Kubicha, 1995, Psychopharmacology.

GlycineB antagonists and partial agonists in rodent models of Parkinson’s disease—comparison with uncompetitive N-methyl-d-aspartate receptor antagonist

W. Danysz, B. Lorenz, M. Karcz-Kubicha, 1999, Neuropharmacology.

NMDA receptor antagonists acting at the glycineB site in rat models for antipsychotic-like activity

W. Danysz, K. Wȩdzony, W. Zajaczkowski, 1999, Journal of Neural Transmission.

Anxiolytic activity of glycine-B antagonists and partial agonists—No relation to intrinsic activity in the patch clamp

C. Parsons, W. Danysz, S. Hartmann, 1997, Neuropharmacology.

Evidence for an anxiogenic action of AMPA receptor antagonists in the plus-maze test.

S. Liljequist, M. Karcz-Kubicha, 1995, European journal of pharmacology.

Role of central and peripheral adenosine receptors in the cardiovascular responses to intraperitoneal injections of adenosine A1 and A2A subtype receptor agonists

E. Thorndike, S. Goldberg, S. Ferré, 2005, British journal of pharmacology.

Enabling role of adenosine A1 receptors in adenosine A2A receptor‐mediated striatal expression of c‐fos

M. Morales, B. Hope, S. Goldberg, 2003, The European journal of neuroscience.

Caffeine Induces Dopamine and Glutamate Release in the Shell of the Nucleus Accumbens

S. Goldberg, S. Ferré, P. Popoli, 2002, The Journal of Neuroscience.

Psychostimulant pharmacological profile of paraxanthine, the main metabolite of caffeine in humans

C. Lluis, Z. Justinova, S. Ferré, 2013, Neuropharmacology.

Zona incerta-lateral hypothalamus as an output structure for impulses involved in neuroleptic drug-induced catalepsy

K. Ossowska, S. Wolfarth, J. Wardas, 1993, Naunyn-Schmiedeberg's Archives of Pharmacology.

Genetic aspects on the effects of ethanol and central stimulants on locomotor activity and brain dopamine metabolism in mice.

S. Liljequist, M. Karcz-Kubicha, 1993, Alcohol and alcoholism (Oxford, Oxfordshire). Supplement.